Authors: DEMETER LM DAQUILA R WEISLOW O LORENZO E ERICE A FITZGIBBON J SHAFER R RICHMAN D HOWARD TM ZHAO YQ FISHER E HUANG D MAYERS D SYLVESTER S ARENS M SANNERUD K RASHEED S JOHNSON V KURITZKES D REICHELDERFER P JAPOUR A

Citation: Lm. Demeter et al., INTERLABORATORY CONCORDANCE OF DNA-SEQUENCE ANALYSIS TO DETECT REVERSE-TRANSCRIPTASE MUTATIONS IN HIV-1 PROVIRAL DNA, Journal of virological methods, 75(1), 1998, pp. 93-104

Authors: BADLEY AD DOCKRELL DH ALGECIRAS A ZIESMER S LANDAY A LEDERMAN MM CONNICK E KESSLER H KURITZKES D LYNCH DH ROCHE P YAGITA H PAYA CV

Citation: Ad. Badley et al., IN-VIVO ANALYSIS OF FAS FASL INTERACTIONS IN HIV-INFECTED PATIENTS/, The Journal of clinical investigation, 102(1), 1998, pp. 79-87

Authors: SCHOOLEY RT RAMIREZRONDA C LANGE JMA COOPER DA LAVELLE J LEFKOWITZ L MOORE M LARDER BA STCLAIR M MULDER JW MCKINNIS R PENNINGTON KN HARRIGAN PR KINGHORN I STEEL H ROONEY JF RAY MG KURITZKES D RIVERAVASQUEZ C SANTANA J VANLEEUWEN R BOUCHER C REISS P VEENSTRA J KEET R PIERCE P HAAS D BARNES B LOEWENTHAL M DARCYEVANS C KEMP S KOHLI A MYERS R YEO J EMERY S ROMERO C ANDREWS J HANSON C SHORTINO D PATTISHALL K BARRY D

Citation: Rt. Schooley et al., VIROLOGICAL AND IMMUNOLOGICAL BENEFITS OF INITIAL COMBINATION THERAPYWITH ZIDOVUDINE AND ZALCITABINE OR DIDANOSINE COMPARED WITH ZIDOVUDINE MONOTHERAPY, The Journal of infectious diseases, 173(6), 1996, pp. 1354-1366

Authors: CAVERT W COOMBS RW GRIMES J KURITZKES D JOHNSON V KAPPES J STEIN D BEATTY C ERICE A WINTERS M KATZENSTEIN D JOHNSON E ROJO E MIRABILE M ELBEIK T TSIATIS B COREY L

Citation: W. Cavert et al., THERAPEUTIC SIGNIFICANCE OF SWITCHING TO DIDANOSINE (DDI) OR ADDING DDI IN SUBJECTS WITH ZIDOVUIDINE-RESISTANT HIV-1, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 41-41

Authors: SULLIVAN S AYERS D CAMPBELL T KURITZKES D SHERRER J SCHOOLEY R

Citation: S. Sullivan et al., LIPOSOME UPTAKE BY HUMAN PRIMARY LYMPHOBLASTS, Journal of cellular biochemistry, 1993, pp. 23-23